Active Ingredient History
Tetraglycine hydroperiodide is an iodine-containing chemical, used for water purification. Tetraglycine hydroperiodide is marketed in tablets; each tablet effectively disinfects 1 liter of clear water or 0.5 liter of tainted water by releasing approximately 8 mg free iodine. It requires approximately 30 minutes to inactivate target microorganisms and make water bacteriologically suitable for drinking. To remove iodine taste, a vitamin C pill is added to the kit. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Amputation (Phase 4)
Breast Neoplasms (Phase 4)
Cariostatic Agents (Phase 3)
Coronary Artery Disease (Phase 4)
Coronary Stenosis (Phase 4)
Coronavirus Infections (Phase 1/Phase 2)
COVID-19 (Phase 1/Phase 2)
Dental Caries (Phase 3)
Dental Plaque (Phase 3)
Endoscopy (Phase 4)
Esophageal Neoplasms (Phase 4)
Fetal Nutrition Disorders (Phase 4)
Fibrocystic Breast Disease (Phase 3)
Gingivitis (Phase 2)
Graves Disease (Phase 4)
Healthy Volunteers (Phase 4)
Hepatitis C, Chronic (Phase 3)
Hysterectomy (Phase 4)
Inflammation (Phase 2)
Irritants (Phase 2)
Liver Neoplasms (Phase 3)
Neurodevelopmental Disorders (Phase 4)
Otitis Media (Phase 3)
Pain (Phase 4)
Pituitary Neoplasms (Phase 2)
Pregnancy Complications (Phase 4)
SARS-CoV-2 (Phase 1/Phase 2)
Wound Infection (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue